Estudi neurofisiològic del control executiu de l'atenció en l'esquizofrènia

Report for the scientific sojourn carried out at the Departament de Psicologia de la Universitat de les Illes Balears, Spain, from May until July 2006. Abnormalities in executive functions, including set shifting ability, represent a cardinal feature in schizophrenia. This ability to adapt behavior to changing environmental events or contingencies requires a mechanism for switching attention between learned stimulus-response associations, or task-sets. This project aimed at gaining further knowledge on the brain mechanisms related to the executive control of attention in schizophrenia during the performace of a task switching paradigm. Furthermore, a secondary goal was to further examine the interrelationships between endogenous and exogenous control processes in task set switching.

Símptomes negatius i cognició social en l'esquizofrènia : un programa d'intervenció

L’esquizofrènia és un trastorn mental greu que afecta a un 1% de la població mundial. El seu tractament ha estat molt estudiat i, al llarg del temps, s’han descobert i fomentat noves línies de treball com són el tractament de la simptomatologia negativa i el dèficit cognitiu, front l’originària focalització en els símptomes positius. El present programa d’intervenció té com objectiu principal la millora de la simptomatologia negativa i el funcionament social en les persones diagnosticades d’esquizofrènia negativa. El programa es situa en el buit existent entre els programes de rehabilitació cognitiva (RC) i els programes de reinserció laboral i vocacionals donat que els actual programes d’entrenament en habilitats socials han demostrat no ser aplicables a la vida diària dels pacients esquizofrènics. El programa té un format grupal i una duració de 3 anys, amb una sessió setmanal, i consta de 4 mòduls diferenciats (Entrevista Motivacional, Cognició, Simptomatologia negativa i relacions socials, Cloenda i Recopilació de conceptes) amb objectius, dificultat i temporalitat diferents. Les possibles limitacions del programa vindrien donades per la dificultat de determinar quins són els pacients que s’adequarien a aquesta intervenció, pel que serà necessària la realització d’una adequada avaluació per seleccionar els membres del grup de tractament. Alhora, en la seva aplicació, les limitacions vindrien determinades per la forta implicació emocional i cohesió grupal que el programa requereix.

Tendência temporal da esquizofrenia: um estudo realizado no âmbito hospitalar

OBJETIVO: Verificar as variações quanto a sexo, idade, número e tempo de internação em pacientes com esquizofrenia. MÉTODOS: O estudo foi realizado no Hospital Doutor João Machado, referência estadual psiquiátrica, situado em Natal/RN - Brasil, no período de 1999 a 2005. O número de casos, o tempo de internação, a idade e o sexo foram coletados. Esses dados foram analisados pela estatística descritiva e Teste de Mann-Whitney com nível de significância de 5%. RESULTADOS: Durante esse tempo, 12.732 pessoas foram internadas. Os portadores de esquizofrenia corresponderam a 35,35% (4.501). A permanência no hospital foi de 44,33 ± 36,9 dias, diferente daquela observada nos não-portadores de esquizofrenia, 29,5 ± 61,6 dias (p < 0,0001). A idade média foi de 38,7 ± 13,5 anos, sendo a maioria dos pacientes do sexo masculino (65,78%). Em 1999, de cada 100 internados, 39,8 eram portadores de esquizofrênia; em 2005 essa proporção reduziu-se para 30,1. A esquizofrenia paranóide foi a mais freqüente, ocorrendo em 1.829 (40%) dos pacientes durante o período. CONCLUSÕES: O estudo aponta uma tendência à redução no número de doentes internados com esquizofrenia, bem como uma diminuição no tempo de internação.

La utilització dels "serious games" en el tractament dels trastorns mentals : una revisió

Aquest article de revisió analitza l'ús que s'està fent dels anomenats "serious games" en el tractament dels trastorns mentals. La recerca efectuada a les bases de dades Medline i PsycINFO han donat com a resultat la localització de 537 articles que fan referència als "serious games" i als "computer games", dels quals 71 ho fan a la seva aplicació en l'àmbit de la salut i 14 a l'àmbit mes concret dels trastorns mentals. S'han trobat estudis que contemplen tractaments per l'esquizofrènia, el Trastorn per Dèficit d'Atenció i Hiperactivitat (TDAH), el Trastorn per Estrès Posttraumàtic (TEPT), l'autisme, el retard mental i les fòbies. Hi ha resultats encoratjadors en quan a l'eficàcia dels tractaments utilitzant jocs d'ordinador, realitat virtual i realitat augmentada, si bé degut a ser un camp de recerca molt jove es necessita replicar molts estudis per tal de donar validesa científica als resultats provisionals obtinguts.

Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta (2) adrenergic receptor template

Schizophrenia is a devastating mental disorder that has a largeimpact on the quality of life for those who are afflicted and isvery costly for families and society.[1] Although the etiology ofschizophrenia is still unknown and no cure has yet beenfound, it is treatable, and pharmacological therapy often producessatisfactory results. Among the various antipsychoticdrugs in use, clozapine is widely recognized as one ofthemost clinically effective agents, even if it elicits significant sideeffects such as metabolic disorders and agranulocytosis. Clozapineand the closely related compound olanzapine are goodexamples ofdrug s with a complex multi-receptor profile ;[2]they have affinities toward serotonin, dopamine, a adrenergic,muscarinic, and histamine receptors, among others.

Dèficits neuromotors en trastorns de personalitat de l'espectre esquizofrènic : Una visió neuro-anatòmica

Aquest estudi pretén aprofundir, mitjançant tècniques de neuroimatge, en la cerca de diferències volumètriques, tant en volum de substància gris com blanca, que presenten els pacients de trastorns de personalitat esquizoide i esquizotípic amb relació amb un grup control.

Prevalença de factors de risc cardiovascular i qualitat de vida en pacients amb trastorn mental sever

L’objectiu és descriure els factors de RCV i variables relacionades amb la qualitat de vida de pacients amb TMS. Estudi transversal on s’analitzen variables clíniques, antropomètriques, anàlitiques i d’estils de vida en 212 pacients. Distribució dels factors de RCV: 61,6% tabaquisme, 84,4% perímetre de cintura alterat, 67,5% obesitat, 15% hipercolesterolèmia, 41,1% hipertrigliceridèmia i 27,8% HTA. La qualitat de vida percebuda és pitjor en la majoria de dimensions respecte a població general. Calen estudis per a determinar intervencions efectives per a millorar el control metabòlic i la qualitat de vida en aquests pacients.

Childhood adversity and psychosis: examinig whether the association is due to genetic confounding using a monozygotic twin differences approach

Purpose: To test whether the association between childhood adversity and positive and negative psychotic experiences is due to genetic confounding. Method: Childhood adversity and psychotic experiences were assessed in a sample of 226 twins from the general population. A monozygotic (MZ) twin differences approach was used to assess possible genetic confounding. Results: In the whole sample, childhood adversity was significantly associated with positive (β =.45; SE=.16; p=.008) and negative psychotic experiences (β=.77; SE=.18; p<.01). Within-pair MZ twin differences in exposure to childhood adversity were significantly associated with differences in positive (β =.71; SE=.29; p=.016) and negative psychotic experiences (β =.98; SE=.38; p=.014) in a subsample of 86 MZ twin pairs. Conclusions: Individuals exposed to childhood adversity are more likely to report psychotic experiences. Furthermore, our findings indicate that unique environmental effects of childhood adversity contribute to the development of psychotic experiences.

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

Background: Atypical antipsychotics provide better control of the negative and affective symptoms of schizophrenia when compared with conventional neuroleptics; nevertheless, their heightened ability to improve cognitive dysfunction remains a matter of debate. This study aimed to examine the changes in cognition associated with long-term antipsychotic treatment and to evaluate the effect of the type of antipsychotic (conventional versus novel antipsychotic drugs) on cognitive performance over time. Methods: In this naturalistic study, we used a comprehensive neuropsychological battery of tests to assess a sample of schizophrenia patients taking either conventional (n = 13) or novel antipsychotics (n = 26) at baseline and at two years after. Results: Continuous antipsychotic treatment regardless of class was associated with improvement on verbal fluency, executive functions, and visual and verbal memory. Patients taking atypical antipsychotics did not show greater cognitive enhancement over two years than patients taking conventional antipsychotics. Conclusions Although long-term antipsychotic treatment slightly improved cognitive function, the switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of these cognitive deficits.

Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics

Purpose: To describe (1) the clinical profiles and the patterns of use of long-acting injectable (LAI) antipsychotics in patients with schizophrenia at risk of nonadherence with oral antipsychotics, and in those who started treatment with LAI antipsychotics, (2) health care resource utilization and associated costs. Patients and methods: A total of 597 outpatients with schizophrenia at risk of nonadherence, according to the psychiatrist's clinical judgment, were recruited at 59 centers in a noninterventional prospective observational study of 1-year follow-up when their treatment was modified. In a post hoc analysis, the profiles of patients starting LAI or continuing with oral antipsychotics were described, and descriptive analyses of treatments, health resource utilization, and direct costs were performed in those who started an LAI antipsychotic. Results: Therapy modifications involved the antipsychotic medications in 84.8% of patients, mostly because of insufficient efficacy of prior regimen. Ninety-two (15.4%) patients started an LAI antipsychotic at recruitment. Of these, only 13 (14.1%) were prescribed with first-generation antipsychotics. During 1 year, 16.3% of patients who started and 14.9% of patients who did not start an LAI antipsychotic at recruitment relapsed, contrasting with the 20.9% who had been hospitalized only within the prior 6 months. After 1 year, 74.3% of patients who started an LAI antipsychotic continued concomitant treatment with oral antipsychotics. The mean (median) total direct health care cost per patient per month during the study year among the patients starting any LAI antipsychotic at baseline was 1,407 ( 897.7). Medication costs (including oral and LAI antipsychotics and concomitant medication) represented almost 44%, whereas nonmedication costs accounted for more than 55% of the mean total direct health care costs. Conclusion: LAI antipsychotics were infrequently prescribed in spite of a psychiatrist-perceived risk of nonadherence to oral antipsychotics. Mean medication costs were lower than nonmedication costs.

Family impact in intellectual disability, severe mental health disorders and mental health disorders in ID. A comparison

Family impact (or family burden) is a concept born in the field of mental health that has successfully been exported to the ambit of intellectual disability (ID). However, differences in family impact associated with severe mental health disorders (schizophrenia), to ID or to mental health problems in ID should be expected. Seventy-two adults with intellectual disability clients of the Carmen Pardo-Valcarce Foundation's sheltered workshops and vocational employment programmes in Madrid (Spain), 203 adults diagnosed with schizophrenia from four Spanish Community Mental Health Services (Barcelona, Madrid, Granada and Navarra) and 90 adults with mental health problems in ID (MH-ID) from the Parc Sanitari Sant Joan de Déu Health Care Site in Sant Boi de Llobregat, Barcelona (Spain) were asked to participate in the present study along with their main caregivers. Family impact experienced by caregivers was assessed with the ECFOS-II/SOFBI-II scale (Entrevista de Carga Familiar Objetiva y Subjetiva/Objective and Subjective Family Burden Interview). In global terms, results showed that the higher family impact was found between caregivers to people with MH-ID. The interaction of both conditions (ID and mental health problems) results in a higher degree of burden on families than when both conditions are presented separately. There was also an impact in caregivers to people with schizophrenia, this impact being higher than the one detected in caregivers to people with intellectual disability. Needs of caregivers to people with disability should be addressed specifically in order to effectively support families.

Intervención clínica de enfermería. Esquizofrenia paranoide

El número de personas que padecen problemas psiquiátricos y sus consecuencias está aumentando de forma alarmante en el mundo, según el Informe Mundial sobre Salud Mental de la Organización Mundial de la Salud, debido “al envejecimiento de la población, la agudización de los problemas sociales y los desórdenes públicos”.

A comparison of the dental status and treatment needs of older adults with and without chronic mental illness in Sevilla, Spain

Objectives: To study the dental status and treatment needs of institutionalized older adults with chronic mental illness compared to a non-psychiatric control sample. Study Design: The sample size was 100, in which 50 were psychogeriatric patients (study group; SG) classified according to DSM-IV, with a mean age of 69.6 ± 6.7 years, and 50 non-psychiatric patients (control group; CG), with a mean age of 68.3 ± 6.9 years. Clinical oral health examinations were conducted and caries were recorded clinically using the Decayed, Missing and Filled Teeth Index (DMFT). Results were analyzed statistically using the Student"s t-test or analysis of variance. Results: Caries prevalence was 58% and 62% in SG and CG, respectively. DMFT index was 28.3 ± 6.6 in SG and 21.4 ± 6.07 in CG (p < 0.01). Mean number of decayed teeth was higher in SG (3.1) compared to CG (1.8) (p=0.047). Mean number of missing teeth were 25.2 and 16.4 in SG and CG respectively (p<0.05). DMFT scores were higher in SG in all the age groups (p < 0.01). Mean number of teeth per person needing treatment was 3.4 in SG and 1.9 in CG (p= 0.037). The need for restorative dental care was significantly lower in the SG (0.8 teeth per person) than in the CG (1.7 teeth per person) (p = 0.043). Conclusions: Institutionalized psychiatric patients have significantly worse dental status and more dental treatment needs than non-psychiatric patients.

Brain functional abnormality in schizo-affective disorder: an fMRI study.

Background.Schizo-affective disorder has not been studied to any significant extent using functional imaging. The aim of this study was to examine patterns of brain activation and deactivation in patients meeting strict diagnostic criteria for the disorder. METHOD: Thirty-two patients meeting research diagnostic criteria (RDC) for schizo-affective disorder (16 schizomanic and 16 schizodepressive) and 32 matched healthy controls underwent functional magnetic resonance imaging (fMRI) during performance of the n-back task. Linear models were used to obtain maps of activations and deactivations in the groups. RESULTS: Controls showed activation in a network of frontal and other areas and also deactivation in the medial frontal cortex, the precuneus and the parietal cortex. Schizo-affective patients activated significantly less in prefrontal, parietal and temporal regions than the controls, and also showed failure of deactivation in the medial frontal cortex. When task performance was controlled for, the reduced activation in the dorsolateral prefrontal cortex (DLPFC) and the failure of deactivation of the medial frontal cortex remained significant. CONCLUSIONS: Schizo-affective disorder shows a similar pattern of reduced frontal activation to schizophrenia. The disorder is also characterized by failure of deactivation suggestive of default mode network dysfunction.

Brain functional abnormality in schizo-affective disorder: an fMRI study.

Background.Schizo-affective disorder has not been studied to any significant extent using functional imaging. The aim of this study was to examine patterns of brain activation and deactivation in patients meeting strict diagnostic criteria for the disorder. METHOD: Thirty-two patients meeting research diagnostic criteria (RDC) for schizo-affective disorder (16 schizomanic and 16 schizodepressive) and 32 matched healthy controls underwent functional magnetic resonance imaging (fMRI) during performance of the n-back task. Linear models were used to obtain maps of activations and deactivations in the groups. RESULTS: Controls showed activation in a network of frontal and other areas and also deactivation in the medial frontal cortex, the precuneus and the parietal cortex. Schizo-affective patients activated significantly less in prefrontal, parietal and temporal regions than the controls, and also showed failure of deactivation in the medial frontal cortex. When task performance was controlled for, the reduced activation in the dorsolateral prefrontal cortex (DLPFC) and the failure of deactivation of the medial frontal cortex remained significant. CONCLUSIONS: Schizo-affective disorder shows a similar pattern of reduced frontal activation to schizophrenia. The disorder is also characterized by failure of deactivation suggestive of default mode network dysfunction.